(firstQuint)Subconjunctival Bevacizumab and Recurrent Pterygium.

 1.

 Pacients with recurrent pterygium 2.

 Anti-VEGF therapy -Bevacizumab.

 Subconjunctival Bevacizumab and Recurrent Pterygium@highlight

A study to research whether subconjunctival bevacizumab injection may potentially suppress neovascularization in pterygium, retarding and decreasing the size of recurrent pterygium.

